 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. NASDAQ: LOGC between December 3, 2018 and February 10, 2020, inclusive the Class Period of the important May 18, 2020 lead plaintiff deadline in the class action first filed by the firm. The lawsuit seeks to recover damages for LogicBio investors under the federal securities laws. 